Trends in All-Cause, Cardiovascular, and Noncardiovascular Mortality Among US Adults With Hypertension
Eunhee Choi,Daichi Shimbo,Ligong Chen,Kathryn Foti,Lama Ghazi,Shakia T Hardy,Paul Muntner,Shakia T. Hardy
DOI: https://doi.org/10.1161/hypertensionaha.123.22220
IF: 9.8968
2024-02-25
Hypertension
Abstract:Hypertension, Ahead of Print. Background:Death certificate data indicate that hypertension may have increased as a contributing cause of death among US adults. Hypertension is not commonly recorded on death certificates although it contributes to a substantial proportion of cardiovascular disease (CVD) deaths.Methods:We estimated changes in all-cause, CVD, and non-CVD mortality over 5 years of follow-up among 4 cohorts of US adults with hypertension using mortality follow-up data from National Health and Nutrition Examination Survey III in 1988 to 1994, and National Health and Nutrition Examination Survey cycles from 1999 to 2000 through 2015 to 2016 (n=20 927). Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or antihypertensive medication use. Participants were grouped according to the date of their National Health and Nutrition Examination Survey study visit (1988–1994, 1999–2004, 2005–2010, 2011–2016).Results:There were 2646, 1048, and 1598 all-cause, CVD, and non-CVD deaths, respectively. After age, gender, and race/ethnicity adjustment and compared with the 1988 to 1994 cohort, the hazard ratio of all-cause mortality was 0.88 (95% CI, 0.76–1.01) for the 1999 to 2004 cohort, 0.82 (95% CI, 0.70–0.95) for the 2005 to 2010 cohort, and 0.89 (95% CI, 0.75–1.05) for the 2011 to 2016 cohort (Ptrend=0.123). The age, gender, and race/ethnicity-adjusted hazard ratios for CVD mortality compared with the 1988 to 1994 cohort were 0.74 (95% CI, 0.60–0.90) for the 1999 to 2004 cohort, 0.61 (95% CI, 0.50–0.74) for the 2005 to 2010 cohort, and 0.57 (95% CI, 0.44–0.74) for the 2011 to 2016 cohort (Ptrend <0.001). There was no evidence of a change in CVD mortality between the 2005 to 2010 and 2011 to 2016 cohorts (P=0.661). Noncardiovascular mortality did not decline over the study period (Ptrend=0.145).Conclusions:The decline in CVD mortality among US adults with hypertension stalled after 2005 to 2010.
peripheral vascular disease